Ikena Oncology
IPORedefining targeted oncology therapies
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- ikenaoncology.com
- Total Funding
- $195.0M
- Last Round
- $75.0M Private EquityJul 2025
- Rounds
- 3
- Type
- Public
About
Ikena Oncology was a clinical-stage oncology biotech founded in 2016 in Cambridge/Boston, MA, formerly Kyn Therapeutics. Merged with ImageneBio July 2025.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jul 2025
Jan 2021
Dec 2017
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.